Stockchase Opinions

Jim Cramer - Mad Money ChemoCentryx CCXI-Q DON'T BUY Aug 15, 2022

A biotech with shares that more than doubled on a single day on a takeover bid by Biogen. At best, you'll make over a dollar per share if the deal goes ahead. If not, you will lose a fortune. Avoid.
$50.820

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.